Literature DB >> 16202051

Hepatitis B virus DNA in blood donors with anti-HBc as a possible indicator of active hepatitis B virus infection in Yucatan, Mexico.

B M García-Montalvo1, J A Farfán-Ale, K Y Acosta-Viana, F I Puerto-Manzano.   

Abstract

Hepatitis B virus (HBV) may be present in serum even when negative for HBV surface antigen (HBsAg). If routine screening of sera for anti-HBV core antigen (anti-HBc) is not done, low-level HBV viraemia may not be identified. A study was done on the presence of HBV DNA in serum samples from Mexican blood donors negative for HBsAg. Sera from 158 volunteer blood donors, negative for HBsAg and anti-HBs, but positive for anti-HBc, were analysed using nested polymerase chain reaction (PCR). HBV DNA was detected in sera from 13 (8.23%) of the 158. Specificity of the PCR-amplified products was corroborated using Southern blot. Single strand conformation polymorphism (SSCP) analysis showed identical SSCP-banding patterns for all 13 PCR products, suggesting similar cDNA sequences. Occult HBV infection was observed in approximately 8% of anti-HBc only donors. The absence of HBsAg in the blood of apparently healthy individuals may not be sufficient to ensure lack of circulating HBV, and blood containing anti-HBc only may be infectious until proven otherwise.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16202051     DOI: 10.1111/j.1365-3148.2005.00610.x

Source DB:  PubMed          Journal:  Transfus Med        ISSN: 0958-7578            Impact factor:   2.019


  7 in total

Review 1.  Isolated anti-HBc: The Relevance of Hepatitis B Core Antibody-A Review of New Issues.

Authors:  Tiffany Wu; Ryan M Kwok; Tram T Tran
Journal:  Am J Gastroenterol       Date:  2017-10-31       Impact factor: 10.864

Review 2.  Occult hepatitis B virus infection and blood transfusion.

Authors:  Dong Hee Seo; Dong Hee Whang; Eun Young Song; Kyou Sup Han
Journal:  World J Hepatol       Date:  2015-03-27

3.  Post-transfusion occult hepatitis B (OBI): a global challenge for blood recipients and health authorities.

Authors:  Mohammad Kazemi Arababadi; Gholamhossein Hassanshahi; Ali Akbar Pourfathollah; Ebrahim Rezazadeh Zarandi; Derek Kennedy
Journal:  Hepat Mon       Date:  2011-09       Impact factor: 0.660

Review 4.  Occult HBV infection: a faceless enemy in liver cancer development.

Authors:  Jaime Morales-Romero; Gustavo Vargas; Rebeca García-Román
Journal:  Viruses       Date:  2014-04-08       Impact factor: 5.048

5.  Prevalence of Serologic Hepatitis B Markers in Blood Donors From Puebla, Mexico: The Association of Relatively High Levels of Anti-Core Antibodies With the Detection of Surface Antigen and Genomic DNA.

Authors:  Francisca Sosa-Jurado; Nora Hilda Rosas-Murrieta; Belinda Guzman-Flores; Cintia Perez Zempoaltecalt; Ana Patricia Sanchez Torres; Leticia Ramirez Rosete; Maribel Bernal-Soto; Luis Marquez-Dominguez; Daniel Melendez-Mena; Miguel Angel Mendoza Torres; Maria Teresa Lopez Delgado; Julio Reyes-Leyva; Veronica Vallejo-Ruiz; Gerardo Santos-Lopez
Journal:  Hepat Mon       Date:  2016-06-01       Impact factor: 0.660

6.  Clinical significance of antibody to hepatitis B core antigen in multitransfused hemodialysis patients.

Authors:  Doaa M Elghannam; Rabab M Aly; Enas F Goda; Ehab E Eltoraby; Raghda E Farag
Journal:  Asian J Transfus Sci       Date:  2009-01

7.  Prevalence of hepatitis B & hepatitis C virus infections in potential blood donors in rural Vietnam.

Authors:  Le Viet; Nguyen Thi Ngoc Lan; Phung Xuan Ty; Björn Björkvoll; Hedda Hoel; Tore Gutteberg; Anne Husebekk; Stig Larsen; Eystein Skjerve; Hans Husum
Journal:  Indian J Med Res       Date:  2012-07       Impact factor: 2.375

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.